Login / Signup

Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis.

Anne ConnollyPhoebe WallmanOlubanke DzahiniOliver HowesDavid M Taylor
Published in: Psychopharmacology (2024)
VMAT-2 inhibitors may have antipsychotic activity and may offer promise for treatment of psychosis with the potential for a reduced risk of TD.
Keyphrases
  • systematic review
  • meta analyses
  • bipolar disorder
  • randomized controlled trial
  • combination therapy
  • climate change
  • risk assessment
  • case control